We were engaged by the Canadian International Development Agency to analyze the major cost drivers and market failures associated with international remittances. We subsequently designed and recommended innovative financing mechanisms which could save up to $3.5 billion over five years.

We worked with the Bill and Melinda Gates Foundation to re-evaluate its strategy to further sleeping sickness (Human African Trypanosomiasis, TB gambiense) control efforts, and determine the potential of a push to eliminate the disease.